• Metadoro
  • Products
  • News and analysis

News and analysis

Check market insights shared by our community members
14.01.2025
Tezos Is Seen Hodling above $1.200

Tezos (XTZ) has declined slightly by 0.2% this week, trading at $1.249, following Bitcoin’s (BTC) drop to $89,158, which triggered widespread altcoin sell-offs due to concerns of a potential further decline in BTC to $80,000. However, Bitcoin managed to hold above the critical support level at $89,000-$91,000, offering some relief to the broader crypto market.

Speculation about a shift in U.S. trade policy has provided additional support to crypto assets. Reports suggest the new U.S. administration may pursue a gradual increase in tariffs rather than an abrupt hike, which could help alleviate inflationary pressures and lead to a less aggressive monetary stance from the Federal Reserve.

This development is a positive signal for the cryptocurrency market and may help Tezos maintain its position above the key support level of $1.200.

20.01.2025
Investment Banks Are Ahead of Lenders

An advance guard of the U.S. banking segment has reported for the ending quarter of 2024 ahead of the corporate earnings season's major chapters, which are still coming in and are supposed to make an overall positive contribution. But what's interesting is, the variety of lending institutions performed a solid organic growth in terms of both revenue and pure income, while the essentially investment giants like Goldman Sachs (GS) and BlackRock (BLK) grew up on a much firmer foundation. There is an impression that well-organised asset management, based on proper contextual ad hoc and mid-term stock transactions, is still producing enhanced results when compared to the returns of somewhat shabby loan portfolios at still quite heavy interest rates.

A temporary increase in Blackrock market value was up to 6.5% at its highest intraday point on January 15, following its record ever $11.93 of equity per share (EPS) on an also absolutely highest number of $5.68 billion in quarterly sales. Blackrock's three-month achievements provided a 23.5% annual boost in EPS vs nearly14% expected at EPS of $11.06 per share, which was supposed in analyst pool projections in reputable news outlets like Bloomberg and Reuters. Many investment houses quickly adjusted their price target areas for Blackrock shares, while also keeping Outperform ratings on the stock. As an example, Keefe, Bruyette & Woods (KBW) revised its price goal for Blackrock to $1,180, citing the investment bank's diversified inflows and global expansion growth initiatives which made the company favorably positioning in the eyes of analysts and investors alike. Blackrock is currently traded around $1000 per share.

However, the Goldman Sachs (GS) effect even surpassed the previous case, with an emergence of totally new peaks above $625 on GS charts, where the shares of this widely recognized investment giant had never been before. The weekly gain was more than 11.5% from $560 per share at the closing price on January 10. Goldman Sachs provided last quarter's EPS at $11.95 per share, beating a $8.12 consensus forecast, with its revenue achieving as high as $13.87 billion vs $12.15 billion previously estimated on average. This means that GS net revenues are up 7% YoY but its adjusted income soared by 54%, so that the firm maintains its clear leadership in global investment banking, including merge and acquisition advisory and wealth management services. Such a strong kind of resilience revived inner projections for EPS of $47.50 for fiscal year 2025 and $52.50 for fiscal year 2026. Isn't this a ready-made reason for targets above $650, or even $700 per share in the coming months, or at least before the end of 2025? By the way, Goldman Sachs CEO David Solomon was freshly rewarded by an $80 million stock bonus to stay at the helm for another 5 years, and John Waldron, a chief operating officer who is seen by many as a successor to Solomon, who is 63 now, was also awarded with his retention bonus of the same $80 million in restricted stock. However, the huge crowd of Goldman Sachs investors on Wall Street is hardly feeling offended or sad either, given the stock's crazy growth pace by the banking segment's standards.

The very fact that a cycle of lower borrowing rates has started in 2024 on both sides of the pond is helping the banking environment tremendously, which may in turn expand into a real business so soon, but the process may be happening more slowly than many Wall Street inhabitants would like to see due to a pause in the dovish shift by the Federal Reserve and other financial regulators. Wells Fargo (WFC), which also has an increasingly advanced investment focus among its recovering lending business, gained more than 8% since last week's earnings' report, coming very close to all-time peaks around $78 per share. Shares of JPMorgan Chase (JPM) and Morgan Stanley (MS) also broke their previous price records, but gained within 5% and 7%, while the Bank of America (BAC) failed to add more than 2% for the reporting week, while its quarterly profits and sales were high but still within its previous lofty standards. The smaller part of investment business versus the credit component for the last three banks mentioned above seems like a reasonable justification for this tendency.

14.01.2025
Merck Becomes Interesting to Be Added to a Portfolio

Merck & Co (MRK) stocks have shown signs of becoming a compelling buy opportunity. Over the past six months, the stock has been in a downtrend, declining 29.8% to $94.50 per share. However, since mid-November, MRK has demonstrated a reversal of momentum, rebounding by 10.0% to reach $104.87 on December 5. Following a brief pullback and consolidation period, the stock has retested the downtrend resistance and appears poised to continue its upward trajectory.

With prices currently positioned to target $110.00, this represents a potential 9-10% upside from the present levels. Setting a stop-loss at $93.50 aligns with a prudent risk management strategy, providing protection against further downside while allowing for upside potential. The recent consolidation phase further supports the case for a breakout, making this an attractive moment to consider initiating or adding to a position in MRK.

16.01.2025
Delta Is Taking Off To Update Its Highs

Delta Air Lines stock rose markedly by low double digits in the first ten days of the new year. The U.S. carrier has served more than 200 million customers in 2024, when it was also recognized by J.D. Power, a leading American data analytics and consumer intelligence company, for being No. 1 in First/Business and Premium Economy Passenger Satisfaction. Travelers became more willing to spend extra money for swanky seats when meeting a high level of service. Delta is just positioning itself as the nation's premium airline. And what's more important, its Christmas quarter's earnings reportedly surpassed average analyst pool projections. Driven by stronger travel demand, smart financial management and capacity discipline, Delta business provided last three-months' profit of $1.85 per share vs $1.28 at the same period one year ago, compared to $1.75 in consensus estimates. On January 10, the airline industry leader put its future profit levels within a range between $0.70 and $1 per share in the current quarter through the end of March, while analyst expectations were focused on $0.77 cents, according to data compiled by LSEG. The starting months of each year always perform worse. It is clear that all carriers made losses in the Covid years of 2020-2022, but Delta profits only recovered into a range from $0.25 to $0.45 in the first quarter of 2023 and 2024, respectively, but Q1 profit numbers varied from $0.75 to $0.96 even in the three blessed years before the pandemic. Delta added that it is forecasting annual earnings in excess of $7.35 a share, which would be the highest in its 100-year history, based on its planned revenue growth of 7% to 9% in the March quarter from a year ago. The announcement could be compared to an adjusted profit of $6.16 a share in 2024. The company happily breaks through ticket prices' rising effects, almost undisturbed by a reduction in airline seats in the domestic market, which was peculiar for most carriers. Thus, new expectations created a fertile ground for setting new price records, even though price movements on Delta charts look most convincing among its other American rivals.

By the way, Citigroup analysts freshly updated their outlook on Delta Air Lines shares to raise their price target to $80 from the previous $77, vs the actual range around $65 per share where the stock just came after a reasonable market correction from last week's and all-time highs. Citigroup said it has included factors like higher revenue per available seat mile, projections of slightly lower fuel prices, increased taxation, a minor rise in share count, and the incorporation of fourth-quarter 2024 results into their financial model, which has projected Delta's profit at $7.49 per share in 2024 and $8.72 in 2025. Delta shares are Buy-rated at Citi, and we agree with their positive estimates in general, while keeping in mind even better price goals somewhere between $82.5 and $85.

09.01.2025
VeChain Is Suffering on Rising Borrowing Costs

VeChain (VET) has fallen 12.7% this week, trading at $0.0445, underperforming the broader cryptocurrency market. Bitcoin (BTC), the leading cryptocurrency, has declined by 5.6% to $93,220, with bearish momentum building as it approaches key support at $89,000-$91,000. This decline is largely attributed to tightening monetary conditions in the United States, which continue to weigh on risk assets. Investor confidence is further shaken by significant net outflows from spot BTC-ETFs, which lost $583 million on Wednesday, marking the second-largest single-day outflow on record.

If BTC falls below the critical support level of $89,000-$91,000, VeChain is likely to extend its losses, with prices potentially declining another 10% to $0.0400. A sustained drop in BTC could push VET even lower, towards $0.0300. Conversely, a strong rebound in BTC prices to the $100,000 level could drive VET back up to $0.0500, representing a recovery of approximately 12% from current levels.

To The Moon Stocks: Northrop Grumman

Northrop Grumman stocks are trading close to their highs. That is a very impressive achievement  considering the current general market correction. The company presented a new B-21 Raider, a stealth strategic bomber. This aircraft could be compared to the introduction of a Boeing 787 that was a true milestone in aviation history.

This bomber is projected to replace the B-2 and B-52 models and cost much less that an average $2 billion per one B-2. B-21 is scheduled to fly in 2023, but not many details about the aircraft’s construction has been disclosed. Cloud computing was reported to be used to enhance the control over military objectives achievement.

Analysts suggest that the cost of each B-21 aircraft will not exceed $550 million, while the U.S. Air force is planning to buy from 100 to 175 units. This may bring the Northrop Grumman $55-96 billion, with some revenues to be received in 2023. Revenues from this project are expected to grow significantly in 2024. The company has many military orders, so the price target of $700 per NOC stock seems to be quite achievable.

6019
Aircraft Makers Pitch Up to Prepandemic Skies: Airbus

Boeing’s major peer, European Airbus, is seen to be in a slightly better condition as the latter has more diversified aircraft deliveries. The company’s management is aiming to increase production to 75 commercial aircraft a month with Airbus A320neo as a flagship. The company is moving deliveries for next year as it simply could not produce the number of aircrafts needed to meet  demand.

The company does not have enough qualified employees and is facing a lack of components needed to establish a steady production. Management has revised the production plan from 720 to 700 commercial aircrafts for the year of 2022. Even with this decrease, the plan is questionable as the company produced 495 aircrafts by the beginning of November. During some months production slowed down to 30-40 units, while during some other month is was above 50 units. The peak month for production is usually the last month of the quarter. But there are some positive developments now, as Airbus produced 60 aircrafts in October, beating September by 55 units.

Nevertheless, Airbus must produce 205 aircrafts in the last two months of this year in order to stick to the plan and this seems to be very complicated. The company has 61 aircrafts in production for November and has not managed to produce more than 89 units during the month of December over the last three years.

In order to push stock prices up, Airbus needs to restore production to prepandemic levels. The company delivered 863 commercial aircrafts in 2019, 566 in 2020, and 611 in 2021 and it seems that for 2022 the production figures will not exceed the levels of the past two years by very much. But even if production is above 650 aircrafts, it would be a positive signal for AIR stocks.

5937
Aircraft Makers Pitch Up to Prepandemic Skies: Boeing

BA shares are 50% off their peak values which were reached at the beginning of 2020. But they have been moving upwards over the last two months, beating the broad market in terms of returns. Its stock price has added about 40% since the beginning of October. This upside is closely related to management’s positive forecast of the Free Cash Flow (FCF). FCF was negative at -$4.4 billion in 2021, while this year it is expected to reach $1.5-2 billion on the positive side.  The company is planning to increase its cash generation to $10 billion by 2025. Boeing considers that its existing demand is strong enough to increase production to 50 commercial aircrafts a month, even if deliveries to China are excluded. The is a very bullish signal for BA stocks.

Wide-body aircrafts like Boeing 787 are expected to dominate the market, while its price could exceed narrow-bodied aircrafts by 200%. Boeing received orders to build 106 narrow-bodied aircrafts and 16 wide-body aircrafts in October for $7.9 billion. During the same month last year there were only ten orders, three of which were later canceled  so  the final net value of orders was $360 million. This year Boeing received orders worth $40.1 billion by the end of October, while the company had only $24.8 billion worth of orders for the same period last year. The number of orders improved dramatically because of the Boeing 737 MAX’s return to the sky.

On the negative side the company is facing a staggered schedule of production that is mostly linked to the last month of the quarter when most planes are completed on paper to present better quarterly reports. This year Boeing produced 363 commercial aircrafts for $25 billion up until the end of October compared to 268 aircrafts worth $20.5 billion for the same period last year. So, it is seemingly a positive upside. But, when we dive into details, we see that 51 aircrafts were produced in September, while only 35 were finished in October. So, the production schedule could be compared to a jigsaw with uneven figures.

During the last two years of the pandemic, Boeing started construction of many aircrafts that now need some minor alterations to claim the aircrafts ready for delivery. Thus, Wall Street is not exaggerating about the number of aircrafts produced. Quite the opposite, more stable production is needed to convince investors of the steady recovery path, that would boost aircraft maker stock prices to prepandemic levels.

4847
Major Risks for Tech Giants: Apple

Apple stocks have had a very impressive performance amid a clearly bearish market while losing only 20% of their peak values. However, investors should be prepared for elevated turbulence in these stocks considering the situation in China.

China’s zero-tolerance policy to COVID-19 led to a massive exit of employees from Zhengzhou city plant amid fears over tightening curbs. Over 200,000 workers are rumoured to have left the plant. If this is true, the production of iPhone 14 Pro and iPhone 14 Pro Max would be very complicated with no clear outlook on when it could be resumed. The delivery delay shown on Apple’s website has already hit six weeks. Americans who ordered the brand new IPhone for Thanksgiving Day will only receive it for Christmas now. Meanwhile the last two months of the year are very valuable for any mass-market company in terms of holiday sales.

 

Apple is planning to move iPhone production to India. But that would require years. The company has already invested $75 billion in the Chinese market and now this investment may be at risk as the ruling Communist party in China may put a local ban on the sale of Apple products. China is the third largest market for Apple with the United States at the first place with $153 billion and Europe at the second with $95 billion. Wall Street is expecting Apple’s earning to go up by five percent over the next three years. So, any troubles with production in China may alter these forecasts. 

4973
348

Join our community

Share your professional and amateur observations, exchange experiences, anticipate developments

Category
All
Stocks
Crypto
Etf
Commodities
Indices
Currencies
Energies
Metals
Instruments
Author
All
Metadoro
Contributors